SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-003546
Filing Date
2015-06-22
Accepted
2015-06-22 12:52:29
Documents
5
Period of Report
2015-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gff8k_062215.htm 8-K 31838
2 EXHIBIT 10.2 exh_102.htm EX-10.2 25142
3 EXHIBIT 10.3 exh_103.htm EX-10.3 24044
4 EXHIBIT 10.4 exh_104.htm EX-10.4 27383
5 GRAPHIC logo.jpg GRAPHIC 34309
  Complete submission text file 0001171843-15-003546.txt   157219
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 15944241
SIC: 2834 Pharmaceutical Preparations